Endomorphin-1 and endomorphin-2 show differences in their activation of μ opioid receptor-regulated G proteins in supraspinal antinociception in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 12-18

  Sánchez Blázquez, Pilar ^a,b   Rodríguez Díaz, Marta ^a   DeAntonio, Isabel ^a   Garzón, Javier ^a  

^a CSIC   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CLONIDINE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE SULFATE; MU OPIATE RECEPTOR; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONAZINE; OPIATE ANTAGONIST;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS; ANALGESICS, OPIOID; ANESTHESIA, SPINAL; ANIMALS; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEINS; MALE; MICE; OLIGODEOXYRIBONUCLEOTIDES; OLIGOPEPTIDES; PAIN; PAIN THRESHOLD; PROTO-ONCOGENE PROTEINS; RECEPTORS, OPIOID, MU;

EID: 0344069680     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Befort K, Tabbara L, Bausch S, Chavkin C, Evans C and Kieffer B (1996) The conserved aspartate residue in the third putative transmembrane domain of the δ-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol Pharmacol 49:216-223.
2. Borsodi A, Spetea M, Monory K, Biyashev D, Tömböly Cs, Tzavara E, Bourin M-C, Matthes HW, Kieffer BI, Benyhe S, Hanoune J and Toth G (1998) In vitro binding and signaling profile of the novel μ opioid receptor agonists, endomorphins in different systems. Proceedings of the 29th International Narcotics Research Conference; 1998 Jul 20-25; Garmisch-Partenkirchen, Germany. Garmisch-Partenkirchen, Germany: International Research Conference Abstracts.
3. 5]-enkephalin-μ-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation. J Neurochem 71:231-239.
4. Eason MG, Kurose H, Holt BD, Raymond JR and Liggett SB (1992) Simultaneous coupling of alpha 2-adrenergic receptor to two G-proteins with opposing effects: Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. J Biol Chem 267:15795-15801.
5. Fukuda K, Kato S and Mon K (1995) Location of regions of the opioid receptor involved in selective agonist binding. J Biol Chem 210:6702-6709.
6. Garzón J, Cástro MA, Juarros JL and Sánchez-Blázquez P (1994) Antibodies raised against the N-terminal sequence of δ opioid receptors demonstrate δ-mediated supraspinal antinociception. Life Sci 54:PL191-PL196.
7. q-transducer proteins in the production of analgesia in the mouse. Analgesia 1:429-432.
8. Garzón J, Castro M and Sánchez-Blázquez P (1998) Influence of Gz and Gi2 transducer proteins in the activity of opioid agonists to μ receptors. Eur J Neurosci 10:2557-2564.
9. Garzón J, DeFelipe J, Rodríguez JR, DeAntonio I, García-España A and Sánchez-Blázquez P (1999) Transport of CSF antibodies to Gα subunits across neural membranes requires binding to the target protein and protein kinase C activity. Mol Brain Res 65:151-166.
10. Garzón J, García-España A and Sánchez-Blázquez P (1997a) Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and Gx/z transducer proteins in mouse periaqueductal gray matter. J Pharmacol Exp Ther 281:549-557.
11. Garzón J, Martínez-Peña Y and Sánchez-Blázquez P (1997b) Gx/z is regulated by mu but not delta opioid receptors in the stimulation of the low Km GTPaae activity in mouse periaqueductal grey matter. Eur J Neurosci 9:1194-1200.
12. αN-Acetyl derivatives of α-endorphin (1-31) and (1-37) regulate the supraspinal antinociceptive activity of different opioids in mice. Life Sci 48:1417-1427.
13. Garzón J and Sánchez-Blázquez P (1995) In vivo injection of antibodies directed against the cloned μ opioid receptor blocked supraspinal analgesia induced by μ-agonists in mice. Life Sci 56:PL237-PL242.
14. Kenakin TP and Morgan PH (1988) Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol Pharmacol 35:214-222.
15. iα1, selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: Identification of the functional domains of this a subunit necessary for mediating the inhibition by somatostatin of cAMP formation. Mol Pharmacol 45:587-590.
16. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF and Wei LN (1998) Mu opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality. Mol Brain Res 54:321-326.
17. Lui YF, Jacobs KH, Rasenick MM and Albert PR (1994) G protein specificity in receptor-effector coupling: Analysis of the roles of Go and Gi2 in GH4Cl pituitary cells. J Biol Chem 289:13880-13886.
18. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, Tzavara E, Hanoune J, Roques BP and Kieffer BI (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature (Lond) 383:819-823.
19. Matthes HWD, Smadja C, Valverde O, Vonesch J-I, Foutz AS, Boudinot E, Denavit-Saubié M, Severini C, Negri L, Roques BP, Maldonado R and Kieffer BI (1998) Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-receptor. J Neurosci 15:7285-7295.
20. McKenzie FR and Milligan G (1990) δ-Opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2. Biochem J 267:391-398.
21. Meng F, Hoversten MT, Thompson RC, Taylor L, Watson SJ and Akil H (1995) A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors. J Biol Chem 270:12730-12736.
22. q/11. Mol Pharmacol 45:890-898.
23. Raffa RB, Connelly CD and Martinez RP (1992) Opioid efficacy is linked to the LiCl-sensitive, inositol-1,4,5-triphosphate-restorable pathway. Eur J Pharmacol 217:221-223.
24. Raffa RB, Martínez RP and Connelly CD (1994) G-protein antisense oligodeoxynucleotides and μ-opioid supraspinal antinociception. Eur J Pharmacol 258:R5-R7.
25. Robb S, Cheek TR, Hannan FI, Hall LM, Midgley JM and Evans PD (1994) Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J 13:1325-1330.
26. Rossi GC, Standifer KM and Pasternak GW (1995) Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci Lett 198:99-102.
27. Sánchez-Blázquez P, García-España A and Garzón J (1995) In vivo injection of oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J Pharmacol Exp Ther 275:1590-1596.
28. Sánchez-Blázquez P and Garzón J (1988) Pertussis toxin differentially reduces the efficacy of opioids to produce supraspinal analgesia in the mouse. Eur J Pharmacol 152:357-361.
29. i3 transducer proteins. Life Sci 53:PL129-PL134.
30. Sánchez-Blázquez P and Garzón J (1998) Delta-opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J Pharmacol Exp Ther 285:820-827.
31. i2 transducer proteins on μ/δ opioid mediated supraspinal antinociception. Life Sci 53:PL381-PL386.
32. Sánchez-Blázquez P, Martín-Clemente B, Castro MA, García-España A and Garzón J (1996) Antisera to Gα subunits of Gi and Gx/z transducer proteins impair the supraspinal antinociceptive effect of neurotensin and clonidine in mice. Analgesia 2:117-123.
33. iα2 protein and mRNA abundance in the mouse. Mol Brain Res 59:247-255.
34. 35S]GTPγS binding in rat brain: Evidence for partial agonist activity at μ-opioid receptors. J Neurochem 70:1567-1576.
35. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, Miner LI and Uhl GR (1997) Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 94:1544-1549.
36. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH and Journot L (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature (Lond) 368:170-175.
37. Standifer KM, Rossi GC and Pasternak GW (1996) Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits. Mol Pharmacol 50:293-298.
38. Strosberg AD (1991) Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. Eur J Biochem 196:1-10.
39. Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, Wang JB and Uhl GR (1994) μ Opiate receptor: Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem 269:20548-20553.
40. Ueda H, Yoshihara Y, Misawa H, Fukushima N, Ui M, Takagi H and Satoh M (1989) The kyotorphin (tyrosine-arginine) receptor and a selective reconstitution with purified Gi, measured with GTPase and phospholipase C assays. J Biol Chem 264:3732-3741.
41. Wang WW, Shahrestanifaar M, Jin J and Howells RD (1995) Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc Natl Acad Sci USA 92:12436-12440.
42. Ward SJ, Lopresti D and James W (1986) Activity of mu-and delta-selective opioid agonists in the guinea pig ileum preparation: Differentiation into peptide and nonpeptide classes with β-funaltrexamine. J Pharmacol Exp Ther 238:626-632.
43. Xue J-C, Chen C, Zhu J, Kunapuli SP, Kim De Riel J, Yu L and Lui-Chen L-Y (1995) The third extracellular loop of the μ. opioid receptor is important for agonist selectivity. J Biol Chem 270:12977-12979.
44. Zadina JE, Hackler L, Ge L-J and Kastin AJ (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature (Lond) 386:499-502.